TrialFuture oncology (London, England)2025

CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.

Soo J Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.